News

First application in humans: The BioVAT-HF-DZHK20 study intends to investigate the use of heart muscle tissue derived from stem cells for treatment of patients with severe heart failure. The incorporation of heart muscle tissue cultivated in the laboratory is intended to sustainably improve the pumping function of diseased hearts. The

Hearing occurs when sensory hair cells in the inner ear convert sound into neural signals transmitted to the brain. The sensory hair cells have about a dozen communication points with the auditory nerve fibers, called synapses. Scientists from the Institute for Auditory Neuroscience at the University Medical Center Göttingen discovered

Dr. Alexander Dieter, a young neuroscientist and first author of the MBExC publication “μLED‐based optical cochlear implants for spectrally selective activation of the auditory nerve” (published in summer 2020 in the EMBO Molecular Medicine Journal), has been awarded with the doctoral thesis award 2021 of the Studienstiftung des Deutschen Volkes.

The Hector Foundation honors the director of the Max Planck Institute (MPI) for Biophysical Chemistry and member of the MBExC, Patrick Cramer, for his outstanding research in the field of gene transcription. The prize is endowed with 150,000 euros and was awarded at a virtual event on January 29.

Diastolic heart failure can be reliably detected with the help of a newly developed magnetic resonance imaging (MRI) technology, shows a study by the Göttingen partner site of the German Centre for Cardiovascular Research (DZHK). Until now, this was only possible with an invasive cardiac catheter examination, which is very

The research award is one of the most prestigious in Europe and endowed with 500,000 Swiss francs. With this prize the Louis-Jeantet Foundation honors the director at the Max Planck Institute (MPI) for Biophysical Chemistry and member of the MBExC for his pioneering work in the field of gene transcription.

The Cluster of Excellence “Multiscale Bioimaging” (MBExC) welcomes Dr. Carola Gregor and Dr. Antoine Huet as new Junior Fellows starting in January 2021 for 3 years. Dr. Carola Gregor will focus with her project Bioluminescence imaging of neurons and cardiomyocytes  on the bioluminescence system from bacteria to develop new tools

Remdesivir is the first drug against Covid-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral copying machine, called RNA polymerase. Researchers at the Max Planck Institute (MPI) for

Physicist Professor and member of the Excellence Cluster “Multiscale Bioimaging” (MBExC) Jörg Enderlein from the University of Göttingen has been awarded an Advanced Grant by the European Research Council (ERC). The ERC has supported Enderlein’s project – “Single-molecule, metal-induced energy transfer” – since the beginning of January 2021. The grant

Prof. Dr. Tobias Moser receives high distinction from French Fondation Pour l’Audition: “Scientific Grand Prize” 2020 honours his pioneering work on the optical cochlear implant for the treatment of hearing loss. The prize is endowed with 100,000 euros. Link to the press release